Investing.com - Goldman Sachs has reiterated its Buy rating and $8.00 price target on Gossamer Bio Inc. (NASDAQ:GOSS), currently ...

Visitors to the Looney House this weekend found no bullet holes in the walls, no skeletons in the basement, and although there have been rumors of tunnels that lead out of the house to nearby homes, ...

This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed.

Find out the direct holders, institutional holders and mutual fund holders for Gossamer Bio, Inc. (GOSS).

Gossamer Bio, Inc. engages in discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. Its primary product candidate, GB001, ...